Pneumococcal conjugate vaccine for acute otitis media - Yes or no?

Lancet

Volumn 361, Issue 9376, 2003, Pages 2170-2171

  Peltola, Heikki ^a   Schmitt, Joe ^b   Booy, Robert ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; HEPATITIS VACCINE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ABSCESS DRAINAGE; ASPIRATION; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; DEVELOPING COUNTRY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG CONJUGATION; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; DRUG USE; FINLAND; FOLLOW UP; GERMANY; HUMAN; ISRAEL; MUCOSA; MYRINGOTOMY; NETHERLANDS; NOTE; OTITIS MEDIA; PRIORITY JOURNAL; PUS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SEROTYPE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TREATMENT FAILURE; TYMPANOSTOMY TUBE; UNITED STATES; VACCINATION;

EID: 0038167764     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)13784-1     Document Type: Note

References (9)

1. Black S., Shinefield H., Fireman B., et al. Efficacy, safety, and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J. 19:2000;187-195.
2. Eskola J., Kilpi T., Palmu A., et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 344:2001;403-409.
3. Kilpi T, Palmu A, Jokinen J, Käyhty H, Mäkelä PH. Efficacy of conjugate vaccine against acute otitis media (AOM) - Finnish experience. 3rd International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD). Anchorage, AL, May 5-8, 2002: 110.
4. Dagan R., Fraser D. Conjugate pneumococcal vaccine and antibiotic-resistant Streptococcus pneumoniae: herd immunity and reduction of otitis morbidity. Pediatr Infect Dis J. 19:2000;S79-S88.
5. von Kries R., Hermann M., Schmitt H.J., et al. Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children. Pediatr Infect Dis J. 21:2002;1-2.
6. Obaro S., Adegbola R.A., Banya W.A., Greenwood B.M. Carriage of pneumococci after pneumococcal vaccination. Lancet. 348:1996;272.
7. Dagan R., Sikuler-Cohen M., Zamir O., Janco J., Givon-Lavi N., Fraser D. Effect of conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees. Pediatr Infect Dis J. 20:2001;951-958.
8. Vernacchio L., Neufeld E.J., MacDonald K., et al. Combined schedule of 7-valent pneumococcal vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease. J Pediatr. 133:1988;275-278.
9. Peltola H. Burden of meningitis and other severe bacterial diseases of children in Africa: implications for prevention. Clin Infect Dis. 31:2001;64-71.